Browse diseases

…s a chronic, nonspecific inflammatory disease of the intestine. Atherosclerosis is considered a chronic inflammatory condition of the vascular …

…as studied in patients (pts) with moderately to severely active ulcerative colitis (UC) in Phase 2 studies. We present efficacy endpoints at week …

…acy and safety of icotrokinra in adults with moderate-to-severe ulcerative colitis (UC) in a phase 2b, randomized, double-blind, placebo-controlle…

…dies [1-3] in patients (pts) with moderately to severely active ulcerative colitis (UC). We report efficacy and safety of two Phase 3, 8-week, ABT…

…tor approved for the treatment of moderately to severely active ulcerative colitis (UC). The impact of concomitant 5-aminosalicyclate acid (5-ASA)…

…those with IBD and worse disease outcomes. However, living with IBD also makes people more susceptible to post traumatic stress (PT…

… is approved for the treatment of moderately to severely active ulcerative colitis (UC). 1 2Methods We report efficacy and safety of UPA from the …

…d Wales (71/76), Azathioprine monotherapy is used first line in ulcerative colitis (33,46.5%) and Crohn’s disease (22,31.0%). Across the UK anti-T…

…Introduction Infliximab (IFX) improves outcomes in Inflammatory Bowel Disease; however secondary loss of response (LOR) occurs in up to 60% o…

… in CD (p=0.027).Conclusions This study reveals an accelerating pIBD burden in a UAE centre, with CD predominance, complex phenotype…

…Objective Inflammatory bowel disease (IBD) is increasingly recognised in the Middle East, but limite…

…P. excrementihominis), a Betaproteobacteria species enriched in ulcerative colitis (UC) patients, is implicated in chronic inflammation. However, …